{"brief_title": "Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone", "brief_summary": "The purpose of this clinical research study is to learn whether a muraglitazar-metformin combination is at least as effective as a glimepiride-metformin combination to treat type 2 diabetics who are not sufficiently controlled with metformin alone. The safety of this treatment will also be studied.", "condition": ["Diabetes Mellitus, Type 2"], "intervention_type": ["Drug"], "intervention_name": ["muraglitazar"], "criteria": "Inclusion Criteria: - Subject with Type 2 diabetes receiving treatment with at least 1,500 mg but not greater than 3000 mg of stable metformin therapy for at least 6 weeks prior to screening - HbA1c >or = 7% and < or = 10% - Fasting c-peptide > or = 1.0 umol - Body Mass Index < or = 41 kg/m2 - Mean serum triglycerides < or = 600 mg/dl", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "keyword": "Diabetes", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Glimepiride", "Metformin", "Glycine"], "id": "NCT00095030"}